We are live on ! Find out more
COLL icon

Collegium Pharmaceutical
COLL

193 hedge funds and large institutions have $1.24B invested in Collegium Pharmaceutical in 2023 Q4 according to their latest regulatory filings, with 33 funds opening new positions, 58 increasing their positions, 77 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

154% more first-time investments, than exits

New positions opened: 33 | Existing positions closed: 13

43% more capital invested

Capital invested by funds: $865M → $1.24B (+$373M)

12.06% more ownership

Funds ownership: 111.28% → 123.34% (+12%)

11% more funds holding

Funds holding: 174 → 193 (+19)

25% less repeat investments, than reductions

Existing positions increased: 58 | Existing positions reduced: 77

67% less funds holding in top 10

Funds holding in top 10: 3 → 1 (-2)

86% less call options, than puts

Call options by funds: $305K | Put options by funds: $2.15M

Holders
193
Holders Change
+19
Holders Change %
+10.92%
% of All Funds
2.81%
Holding in Top 10
1
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-66.67%
% of All Funds
0.01%
New
33
Increased
58
Reduced
77
Closed
13
Calls
$305K
Puts
$2.15M
Net Calls
-$1.85M
Net Calls Change
-$790K

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$35.4M
2
Pacer Advisors
Pacer Advisors
Pennsylvania
+$22.1M
3
PCM
Penn Capital Management
Pennsylvania
+$7.91M
4
Invesco
Invesco
Georgia
+$7.06M
5
Renaissance Technologies
Renaissance Technologies
New York
+$5.31M

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$11.4M
2
RCMNY
Rubric Capital Management (New York)
New York
-$10.4M
3
Janus Henderson Group
Janus Henderson Group
United Kingdom
-$6.33M
4
Marshall Wace
Marshall Wace
United Kingdom
-$6.27M
5
Arrowstreet Capital
Arrowstreet Capital
Massachusetts
-$5.29M
Name Holding Trade Value Shares
Change 		Change in
Stake
Lazard Asset Management
126
Lazard Asset Management
New York
$376K +$306K +12,222 New
MSRPS
127
Maryland State Retirement & Pension System
Maryland
$365K -$23.6K -942 -7%
AIM
128
Aigen Investment Management
New York
$338K +$275K +10,994 New
Wells Fargo
129
Wells Fargo
California
$338K -$7.04K -281 -2%
TRSOTSOK
130
Teachers Retirement System of the State of Kentucky
Kentucky
$329K – – –
BJL
131
Brighton Jones LLC
Washington
$328K – – –
VI
132
Versor Investments
New York
$326K +$33K +1,316 +14%
QT
133
Quantbot Technologies
New York
$307K +$80.2K +3,200 +47%
State Board of Administration of Florida Retirement System
134
State Board of Administration of Florida Retirement System
Florida
$304K – – –
ECM
135
Everence Capital Management
Indiana
$302K +$245K +9,800 New
ASRS
136
Arizona State Retirement System
Arizona
$299K -$3.51K -140 -1%
WAM
137
Watershed Asset Management
California
$294K -$33.8K -1,348 -12%
OPERF
138
Oregon Public Employees Retirement Fund
Oregon
$293K -$20K -800 -8%
EB
139
Eastern Bank
Massachusetts
$287K – – –
RWM
140
Ritholtz Wealth Management
New York
$286K +$233K +9,285 New
Zurich Cantonal Bank
141
Zurich Cantonal Bank
Switzerland
$272K +$49.3K +1,967 +29%
DM
142
Deerfield Management
New York
$267K +$217K +8,667 New
ProShare Advisors
143
ProShare Advisors
Maryland
$263K +$214K +8,545 New
JIC
144
Johnson Investment Counsel
Ohio
$257K +$209K +8,337 New
Teacher Retirement System of Texas
145
Teacher Retirement System of Texas
Texas
$247K -$44.9K -1,794 -18%
HSBC Holdings
146
HSBC Holdings
United Kingdom
$239K +$194K +7,744 New
VA
147
Vident Advisory
Georgia
$239K +$194K +7,755 New
SAM
148
Shell Asset Management
Netherlands
$236K -$58.3K -2,327 -23%
CC
149
Corton Capital
Ontario, Canada
$235K +$191K +7,643 New
GCM
150
Graham Capital Management
Connecticut
$233K -$202K -8,044 -52%
4 5
6
7 8

COLL Hedge Fund Activity: Q4 2023 in Review

193 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Collegium Pharmaceutical (COLL) for Q4 2023, worth a combined $1.24B — up 43% from $865M a quarter earlier.

Buyers outnumbered sellers: 33 funds opened new COLL positions and 13 closed out — a net gain of 20 holders — while 58 added to existing stakes and 77 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $35.4M. The largest seller was BlackRock, cutting an estimated $11.4M.

  • 193 institutional investors held Collegium Pharmaceutical (COLL) as of Q4 2023, up from 174 in Q3 2023.
  • Funds reported $1.24B of Collegium Pharmaceutical stock for Q4 2023, up 43% quarter-over-quarter.
  • 33 funds opened new Collegium Pharmaceutical positions in Q4 2023 and 13 closed out, a net change of +20 holders.
  • The largest Collegium Pharmaceutical buyer in Q4 2023 was Morgan Stanley, an estimated $35.4M added.
  • The largest Collegium Pharmaceutical seller in Q4 2023 was BlackRock, an estimated $11.4M sold.

Based on aggregated 13F filings for Q4 2023.